Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.31 USD | -2.62% | -0.96% | +10.31% |
Mar. 26 | Guggenheim Initiates Voyager Therapeutics With Buy Rating, $22 Price Target | MT |
Mar. 19 | H.C. Wainwright Initiates Coverage on Voyager Therapeutics With Buy Rating, $30 Price Target | MT |
Evolution of the average Target Price on Voyager Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Voyager Therapeutics, Inc.
Guggenheim | |
HC Wainwright | |
Citigroup | |
Wedbush | |
Truist Securities | |
Oppenheimer | |
Chardan Research | |
Chardan | |
Baird | |
BTIG |
EPS Revisions
- Stock
- Equities
- Stock Voyager Therapeutics, Inc. - Nasdaq
- Consensus Voyager Therapeutics, Inc.